Outset Medical surges as FDA clears home dialysis system

Outset Medical

01/08/2022 15:59

** Shares of Outset Medical Inc  OM.O  jump ~29% to $19.89 -
on track to hit the highest levels in seven weeks if gains hold 
    ** Medtech co says it has resumed shipments of its Tablo
home dialysis systems after U.S. Food and Drug Administration
cleared the device for use  urn:newsml:reuters.com:*:nBw6Mp3Y8a 
    ** OM had put a hold on shipments of its systems in June
pending review by the U.S. health regulator  urn:newsml:reuters.com:*:nBw6WG56Ga 
    ** Now sees 2022 revenue between $105 million and $110
million 
    ** Posts Q2 loss per share of 77 cents vs analysts'
expectations of loss of 70 cents per share 
    ** As of last close, stock was down ~57% YTD 

 (Reporting by Bhanvi Satija in Bengaluru)
 ((Bhanvi.Satija@thomsonreuters.com; Outside U.S. +91
9873062788;))